Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ChesnaraCHIX:CSNL -0.29%50 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus rates CHIX:CSNL with a GF Score™ of 50/100 and a GF Value™ of £1.63 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 292 Insurance companies, Chesnara ranks worse than 342465.41% on this metric.
During the past 12 months, Chesnara's average EBITDA Per Share Growth Rate was -17.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Chesnara was 25.10% per year. The lowest was -29.30% per year. And the median was 5.70% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Chesnara 3-Year EBITDA Growth Rate Related Terms
CHIX:CSNL vs AFL, MET, PRU: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Life subindustry, Chesnara's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chesnara 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Chesnara's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Chesnara's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Chesnara (CHIX:CSNL) has a 3-Year EBITDA Growth Rate of 0.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Chesnara and its competitors. According to the industry distribution chart, Chesnara ranks #999999 out of 292 companies in the Insurance industry.
Is Chesnara's 3-Year EBITDA Growth Rate too high?
Chesnara's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Chesnara ranks #999999 out of 292 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Chesnara has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chesnara's 3-Year EBITDA Growth Rate compare to AFL and MET?
According to the Insurance industry distribution chart, Chesnara ranks #999999 out of 292 companies for 3-Year EBITDA Growth Rate. This places Chesnara in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 17.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 17.05, based on 292 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Chesnara and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 17.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chesnara's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chesnara stock overvalued right now?
Based on GuruFocus' analysis, Chesnara (CHIX:CSNL) is currently considered Significantly Overvalued. The stock's GF Value™ is £1.63, compared to a current price of £3.41 — trading 108.9% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Chesnara's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Chesnara (CHIX:CSNL), the current 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chesnara (CHIX:CSNL) Overvalued in 2026?
Based on GuruFocus' analysis, Chesnara stock appears to be overvalued.
The current stock price of £3.41 is trading 108.9% above its estimated GF Value™ of £1.63.
GuruFocus considers Chesnara to be Significantly Overvalued.
Key valuation signals for CHIX:CSNL:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: £1.63 vs. price of £3.41 (108.9% above fair value)
No single metric tells the full story. See the CHIX:CSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chesnara PLC is engaged in the life assurance and pensions business, operating as a consolidator of life insurance and retirement savings portfolios. The Group has three reportable segments: UK, Sweden, and the Netherlands. The UK segment comprises life insurance and pensions operations through Countrywide Assured plc. The Sweden segment includes Movestic, which focuses on unit-linked pension business and provides life and health products. The Netherlands segment represents the combined Dutch life insurance business under the Scildon brand, following the integration of Waard and Scildon, and offers protection, individual savings, and group pension contracts.
50GF Score
Get the complete analysis for CHIX:CSNL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CSNL has been successfully added to your 
